*Department of Medicine, Division of Infectious Disease, Boston University School of Medicine, Boston, MA; and †Dana Farber Cancer Research Center, Boston, MA.
J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):249-53. doi: 10.1097/QAI.0b013e3182a06ddd.
It has been postulated that HIV-1 envelope properties, such as shorter and less-glycosylated V1-V2 loops commonly observed among non-subtype B early-transmitted viruses, promote utilization of the gut homing integrin α4β7. This property potentially confers an advantage to some HIV-1 variants early after acquisition. We found that replication-competent recombinant viruses incorporating HIV-1 subtype A compact and less-glycosylated early versus chronic phase V1-V2 loops demonstrated no significant difference in binding to α4β7 high CD8⁺ T cells or replication in α4β7 high CD4⁺ T cells. Integrin α4β7 usage does not select for shorter less-glycosylated envelopes during transmission.
据推测，HIV-1 包膜的特性，如在非 B 亚型早期传播病毒中常见的更短和更少糖基化的 V1-V2 环，促进了肠道归巢整合素 α4β7 的利用。这种特性可能使一些 HIV-1 变体在获得后的早期具有优势。我们发现，复制型重组病毒中整合了 HIV-1 亚型 A 紧凑和更少糖基化的早期与慢性 V1-V2 环，在与高 CD8+T 细胞上的 α4β7 结合或在高 CD4+T 细胞中的复制方面没有显著差异。整合素 α4β7 的使用在传播过程中不会选择更短和更少糖基化的包膜。
